Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 15, 2003

View Archived Issues

Advectus acquires option for nanopharmaceutical for Alzheimer's disease

Cell Therapeutics Scandinavia and Tanabe enter stem cell collaboration

Probactrix controls antibiotic-associated diarrhea in clinical study

Novel 5-HT6 receptor ligands claimed by GSK researchers

Pierre Fabre presents new alpha2-adrenoceptor modulators with potential in AD therapy

BMS scientists prepare and test new anti-HIV agents

Novel p38 inhibitors, their preparation and use covered by GSK patent

Roche identifies new DPP-IV inhibitors

AstraZeneca claims JNK inhibitors for use in AD and other disorders

Humira approved in E.U. for rheumatoid arthritis

Raptiva recommended for approval by advisory committee

Maxalt launched this month in Japan for migraine Rx

Potent antagonist of human glucagon receptor presented at ACS meeting

Selective ERbeta agonist endowed with potent oral antiinflammatory activity

OncoGenex and Isis expand antisense drug development partnership

AVE-5997, a selective, orally active dopamine D3 antagonist, characterized at ACS meeting

Regeneron to advance phase III Axokine program in obesity

Benicar HCT now available in U.S.

Javlor enters two new phase III trials in NSCLC and bladder cancer

BMS designs series of potent and selective Itk inhibitors as potential immunosuppressants

Enrollment completed in phase I breast cancer trial for HER-2 AutoVac Protein vaccine

Merck presents synthesis, SAR for a series of imidazole acetic acid TAFI inhibitors

FDA accepts for filing diquafosol NDA for dry eye

Phase III results for Genasense plus chemotherapy in malignant melanoma

Genzyme expands access to Myozyme

SBIR grant supports smallpox therapeutic development efforts at Aphios

New fluoroquinolone active against multidrug-resistant Gram-positive pathogens

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 12, 2026
Alzheimer’s, beyond the brain
BioWorld
Researchers at Daping Hospital in China have reported that liver-targeted delivery of the APOE3-Christchurch (APOE3Ch) variant, a rare protective form of...
First cruise ship hantavirus genome points to zoonotic spillover
BioWorld
The initial appraisal of the first complete genome sequence of a hantavirus isolated from a patient in Switzerland who was a passenger on the cruise ship MV...
APAC monitors hantavirus as Singapore isolates 2 from cruise ship
BioWorld
Singapore’s Communicable Diseases Agency on May 7 said that it isolated two residents for hantavirus testing after the individuals disembarked from an Atlantic...